Clinical efficacy and safety analysis in initial hemodialysis patient with renal anemia treated by roxadustat or recombinant human erythropoietin

ObjectiveTo compare the clinical efficacy and safety of roxadustat versus recombinant human erythropoietin (rhEPO) for renal anemia in initial hemodialysis patients.MethodsFrom January 2020 to June 2021, retrospective analysis was performed for 107 patients with renal anemia on hemodialysis. They we...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Peng-jie, Xun Li-ru, Ding Tong, Bao Nan, Duan Bin
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2022-11-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.11.006
Tags: Add Tag
No Tags, Be the first to tag this record!